Is My Dog's Confusion Normal Aging or Early Dementia?

Start here: watch your dog for one week and write down anything that’s changed, not anything that’s simply slow. Slower on stairs is aging. Standing in a corner and forgetting how to back out is not. That distinction is the whole exam, and it’s the one owners skip because both look like “getting old” from across the room.

Do this first, in order:

1. Log sleep-wake timing for seven nights. Note when your dog is up, pacing, or vocalizing. A shift toward nighttime restlessness with daytime napping is one of the more reliable early flags.
2. Watch for disorientation in familiar spaces — standing at the hinge side of a door, getting stuck behind furniture, staring at walls.
3. Track house-training. New accidents in a previously reliable dog, especially indoors right after being let out, matter more than most owners assume.
4. Note social changes. Less greeting behavior, seeming not to “recognize” a family member for a beat, or new clinginess or irritability.
5. Bring the log to your vet rather than trying to self-diagnose. Bloodwork, a thyroid panel, and a pain assessment come first, because pain, UTIs, vision loss, and metabolic disease all mimic dementia in an old dog.

That checklist maps onto what veterinary neurologists actually screen for. The behavioral domains — disorientation, altered social interaction, sleep-wake disruption, house soiling, and changes in activity and anxiety — are collectively known in the literature as DISHAA, and they’re the backbone of every validated screening tool built for this, including the Canine Cognitive Dysfunction Rating Scale (Wikipedia). If your log has hits in three or more of those domains, that’s not “just old,” that’s worth a dedicated cognitive workup.

The dog on the exam table who taught me to stop guessing

A 12-year-old, 58-pound Labrador came in because he’d started barking at the pantry door at 2 a.m., every night, for about three weeks. His owner assumed arthritis pain was waking him. His joints were fine on exam. What had actually changed was his sense of where he was in the house after dark — a disorientation sign, not a pain sign. We ran bloodwork to rule out a metabolic driver, found nothing, and started him on an approach built around sleep-wake support and environmental predictability. By day 10 the nighttime barking had dropped to two or three nights a week. That’s a single dog’s course, not a promise about yours, but it’s the kind of pattern that separates a joint problem from a brain problem if you’re willing to watch for three weeks instead of assuming after one bad night.

Why “she’s just getting old” is the wrong default

Cognitive dysfunction is genuinely common and genuinely underreported. Estimates put the prevalence between roughly 14% and 35% of dogs over eight, rising steeply with age — one study found about 28% affected at 11 to 12 years old, climbing toward 68% by 15 to 16 (Wikipedia). The bigger problem isn’t the disease rate, it’s the reporting gap: surveys of owners of dogs seven and older found that roughly three-quarters had at least one behavior consistent with cognitive decline, but only about one in eight had mentioned it to their vet. Most owners chalk it up to age and never bring it into the exam room.

I understand the instinct. Nobody wants to hear “dementia” about their dog, and it’s genuinely hard to separate a stiff, arthritic 13-year-old’s slower reactions from an actual behavioral domain shift. That’s exactly why a structured log beats a gut feeling — it turns “she seems different” into something a vet can actually score.

Where the workup gets complicated, not clean

Diagnosis in a living dog is still frustratingly indirect. There’s no blood test or scan that confirms cognitive dysfunction the way an X-ray confirms a fracture; clinicians lean on owner-reported questionnaires such as the Canine Cognitive Dysfunction Rating Scale and the Canine Dementia Scale, which are validated but inherently subjective, and researchers are still working to validate blood-based biomarkers that could make this objective (Diagnosis of Canine Cognitive Dysfunction Syndrome: A Narrative Review, PMC). That gap matters for how you should read any online quiz or symptom checklist, including the one above: it’s a starting point for a conversation with your vet, not a diagnosis on its own.

Here’s the case that complicated my own confidence in the checklist approach. A 9-year-old, 22-pound terrier mix came in with what looked like textbook early disorientation — pacing, occasional staring at walls, one accident indoors. Her owner had already started a cognitive-support routine before the visit. It turned out she had a slowly progressive retinal condition that was leaving her functionally blind in dim light, and every “confused” behavior was a vision problem, not a brain problem. We only caught it because a fundic exam is part of the standard rule-out list. The lesson: any single sign on the DISHAA list can come from eyes, ears, pain, or a UTI just as easily as from cognitive decline, so treat the checklist as a reason to test, never as the test itself.

What actually changes outcomes once dementia is confirmed

Once other causes are ruled out, the management options with real evidence behind them fall into a few buckets. Selegiline is the only drug labeled specifically for canine cognitive dysfunction, and it shows measurable improvement in cognitive testing, sleep-wake cycling, and social interaction within 30 to 60 days for a majority of treated dogs (Management of Dogs and Cats With Cognitive Dysfunction, Today’s Veterinary Practice). Separately, diets built around antioxidants, mitochondrial cofactors, and omega-3 fatty acids have shown cognitive benefit in dogs as early as two to eight weeks in, with effects maintained over longer follow-up, and the proposed mechanisms include reducing amyloid buildup and supporting mitochondrial function in aging neurons.

Antioxidant support is where the microbiome and longevity research actually has something to say, though the evidence is uneven across compounds. Quercetin is a flavonoid studied for antioxidant and cellular support properties, but the strongest data on it right now is preliminary — for example, one recent study found that quercetin, alongside NAC and ascorbic acid, did not measurably affect feeding behavior in a lab organism model at the concentrations tested, which is a useful reminder that “antioxidant” doesn’t automatically mean “works for cognition” (DOI.3390/ph19040525). Resveratrol carries a similar caveat: in developmental models, higher-dose embryonic exposure accelerated development but shortened adult lifespan, a signal that dosing and timing matter and that more isn’t automatically better (DOI.1016/j.phymed.2026.158531). None of that is dog-specific cognitive data, and I want to be direct about that rather than stretch it.

That caution matters more here than in a joint-supplement conversation, because supportive supplements are not a treatment for a neurodegenerative disease any more than they’re a treatment for cancer. I say the cancer version of that sentence often enough in my own practice that it’s become reflexive: something can extend quality of life on real evidence without being framed as a cure. The same logic applies to a dog with early cognitive decline. An omega-3-and-antioxidant diet plus selegiline where indicated is a quality-of-life intervention with actual trial support behind it. A joint chew with antioxidant ingredients is not that, and shouldn’t be marketed or understood as if it were.

If your dog also has stiffness alongside the behavioral changes — very common at this age — the joint side of the equation is worth reading on its own terms; see Collagen vs Glucosamine for Aging Dog Joints and Best Joint Supplement for Dogs: An Orthopedic Read of the Label Claims for how to evaluate those ingredients with the same evidence-first standard. If a newer ingredient like alpha-ketoglutarate comes up in that conversation, What Alpha-Ketoglutarate Is—and Whether It’s Safe for Aging Dogs walks through what’s actually known.

Bottom line: slower on stairs, grayer muzzle, less enthusiasm for the mailman — that’s aging. Standing confused in a familiar room, flipped sleep-wake cycles, or new house-soiling in a previously reliable dog is a DISHAA-domain shift worth a dedicated vet visit, bloodwork, and a real rule-out of pain, vision, and metabolic disease before anyone reaches for a supplement aisle answer.